KB Financial Partners’s AbbVie ABBV Stock Holding History

KB Financial Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$20K	Hold	136	–	–	0.01%	345
2023 Q2	$18K	Sell	136 -144	-51%	-$21.1K	﹤0.01%	360
2023 Q1	$45K	Sell	280 -148	-35%	-$22.6K	0.01%	271
2022 Q4	$69K	Sell	428 -91	-18%	-$14K	0.02%	237
2022 Q3	$70K	Buy	519 +24	+5%	+$3.44K	0.03%	224
2022 Q2	$76K	Buy	495 +48	+11%	+$7.33K	0.03%	225
2022 Q1	$72K	Sell	447 -26	-5%	-$3.78K	0.02%	239
2021 Q4	$64K	Buy	+473	New	+$55.9K	0.02%	270
2021 Q3	–	Sell	-1,189	Closed	-$134K	–	163
2021 Q2	$134K	Buy	1,189 +850	+251%	+$95.7K	0.05%	189
2021 Q1	$37K	Buy	+339	New	+$36.3K	0.02%	293

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

KB Financial Partners's ABBV Position: Q3 2023 in Review

KB Financial Partners held its AbbVie (ABBV) position steady in Q3 2023 at 136 shares worth $20K. The position accounts for 0.01% of the portfolio, ranked #345.

KB Financial Partners first reported a position in ABBV in Q1 2021 and has held it in 10 quarters since. The position peaked at $134K in Q2 2021. 3,108 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.

KB Financial Partners held 136 shares of AbbVie worth $20K as of Q3 2023.
KB Financial Partners left its AbbVie share count unchanged in Q3 2023.
AbbVie made up 0.01% of KB Financial Partners's portfolio in Q3 2023, its #345 holding.
KB Financial Partners first reported a position in AbbVie in Q1 2021 and has held it in 10 quarters since.
KB Financial Partners's AbbVie position peaked at $134K in Q2 2021.
3,108 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.

Based on KB Financial Partners's 13F filing for Q3 2023, filed 15 Nov 2023.